Salspera, Inc.
CIK: 0002084032
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type other
State of Incorporation DE
Business Address 45 PROSPECT STREET, CAMBRIDGE, MA, 02139
Mailing Address 45 PROSPECT STREET, CAMBRIDGE, MA, 02139
Phone 652-402-5587
Fiscal Year End 1231
EIN 874698872
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| S-1 IPO registration statement | February 2, 2026 | View on SEC |
IPO Filings
S-1 February 2, 2026
- Salspera is a biopharmaceutical company developing Saltikva, a live biopharmaceutical using engineered bacteria to deliver IL-2 for aggressive cancers like pancreatic cancer and osteosarcoma.
- Saltikva showed promising Phase 2 results for Stage IV pancreatic cancer, significantly improving median Overall Survival (15.2 months vs 10.8 months) and Progression-Free Survival (6.1 months vs 3.5 months).
Related Companies
Companies in the same industry (SIC: 2834)
Werewolf Therapeutics, Inc.
HOWL Pharmaceutical Preparations
Zenas BioPharma, Inc.
ZBIO Pharmaceutical Preparations
Centessa Pharmaceuticals plc
CNTA Pharmaceutical Preparations
Karyopharm Therapeutics Inc.
KPTI Pharmaceutical Preparations
VERTEX PHARMACEUTICALS INC / MA
VRTX Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.